Arestin Microspheres 1 mg (Minocycline (Minocycline Hydrochloride) POWDER (EXTENDED RELEASE)) 1 MG

Minocycline, the active ingredient in Arestin Microspheres 1 mg, inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This prevents the attachment of aminoacyl-tRNA, thereby halting bacterial growth and replication. The extended-release formulation ensures sustained delivery of the antibiotic directly to the infection site, enhancing its efficacy in managing periodontal disease.

The dose of Arestin Microspheres 1 mg is determined by a dental professional based on the individual needs of the patient. Each cartridge contains 1 mg of minocycline hydrochloride and is designed for a single application into a periodontal pocket. The prescriber will determine the appropriate dosage and administration schedule.

Arestin Microspheres 1 mg should be avoided during pregnancy and breastfeeding. The use of tetracycline-class drugs, including minocycline, during tooth development may cause permanent discoloration of the teeth. Therefore, it is not recommended for use in pregnant or breastfeeding women.

To order Arestin Microspheres 1 mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will reply with pricing, availability, shipping, and the necessary import paperwork.

Arestin Microspheres 1 mg is a locally applied antibiotic that delivers a concentrated dose directly to the base of the periodontal pocket. Unlike systemic antibiotics, it targets the infection site specifically, reducing the risk of systemic side effects. It is also bioresorbable, meaning it does not require removal after administration, making it a convenient option for periodontal treatment.

Arestin Microspheres 1 mg should be stored at room temperature in a cool, dry place. It is important to follow the storage instructions provided to maintain the effectiveness of the medication. The medication should be handled with care to avoid contamination and should be kept out of reach of children.

Arestin Microspheres 1 mg is administered by a dental professional using a specially designed cartridge handle. The cartridge is inserted into the handle, and the powder is expressed into the periodontal pocket. The administration process is quick and does not require local anesthesia. Patients should avoid brushing the treated area for 12 hours and abstain from using interproximal cleaning devices for 10 days.

The most serious risks associated with Arestin Microspheres 1 mg include allergic reactions, such as rash, itching, or swelling, and severe irritation or prolonged swelling at the application site. Patients should inform their dental professional if they experience any signs of an allergic reaction or if their symptoms worsen or do not improve.

Arestin Microspheres 1 mg should not be used by individuals who are allergic to minocycline or tetracyclines. It is also not recommended for use in children, pregnant women, or breastfeeding women due to the risk of tooth discoloration. Patients with weakened immune systems, such as those with HIV infections or diabetes, should consult their dental professional before using this medication.